Psychedelic Medicine: The Healing Powers of LSD, MDMA, Psilocybin, and Ayahuasca Audiobook (Free)

Explores the potential of psychedelics while medicine and the intersections of politics, research, and psychedelics

• Explores the tumultuous background of psychedelic study, the efforts to restore psychedelic therapies, and the links between psychiatric drugs and mental disease

• Offers non-technical summaries of the most latest, double-blind, placebo-controlled research with MDMA, psilocybin, LSD, and ayahuasca

• Includes the work of Rick Doblin, Stanislav Grof, Wayne Fadiman, Julie Holland, about Psychedelic Medicine: The Recovery Forces of LSD, MDMA, Psilocybin, and Ayahuasca Dennis McKenna, David Nichols, Charles Grob, Phil Wolfson, Michael and Annie Mithoefer, Roland Griffiths, Katherine MacLean, and Robert Whitaker

Embracing the revival of psychedelic study as well as the discovery of new therapeutic uses, clinical psychologist Dr. Richard Louis Miller discusses what’s occurring today in psychedelic medicine–and what will happen in the future–with top research workers and thinkers in this field, including Rick Doblin, Stanislav Grof, Wayne Fadiman, Julie Holland, Dennis McKenna, David Nichols, Charles Grob, Phil Wolfson, Michael and Annie Mithoefer, Roland Griffiths, Katherine MacLean, and Robert Whitaker.

Dr. Miller and his contributors cover the tumultuous history of early psychedelic research taken to a halt 50 years back from the U.S. federal government as well as offering non-technical summaries of the most recent research with MDMA, psilocybin, LSD, and ayahuasca. They explore the biochemistry of awareness and the use of psychedelics for self-discovery and recovery. They discuss the usage of psilocybin for liberating dread in the terminally ill and the prospect of MDMA-assisted psychotherapy in the treating PTSD. They examine Dr. Charles Grob’s study within the indigenous make use of and therapeutic properties of ayahuasca and Dr. Gabor Mate’s try to transportation this plant medication to a scientific setting by using Canada’s Department of National Wellness.

Dr. Miller and his contributors explore the ongoing attempts to revive psychedelic therapies to the health field, the growing threat of overmedication by the pharmaceutical industry, as well as the links between psychiatric medications and mental illness. In addition they discuss the recently shifting political weather and the press for new study, offering expect an end to the War on Drugs and a potential renaissance of analysis into psychedelic medicines around the world.